Accessibility Menu
Wellgistics Health Stock Quote

Wellgistics Health (NASDAQ: WGRX)

$0.39
(0.0%)
+0.00
Price as of January 21, 2026, 9:52 a.m. ET

KEY DATA POINTS

Current Price
$0.39
Daily Change
(0.0%) +$0.00
Day's Range
$0.39 - $0.40
Previous Close
$0.39
Open
$0.39
Beta
N/A
Volume
116,278
Average Volume
14,205,116
Market Cap
$35M
Market Cap / Employee
$0.39M
52wk Range
$0.34 - $7.04
Revenue
N/A
Gross Margin
-0.01%
Dividend Yield
N/A
EPS
-$1.10
CAPs Rating
N/A
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Wellgistics Health Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
WGRXN/AN/AN/A-90%
S&P+13.34%+76.4%+12.02%+13%
Advertisement

Wellgistics Health Company Info

Wellgistics Health, Inc. operates as a holding company and doing business through its subsidiaries and engages in various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. It business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

News & Analysis

No results found

No news articles found for Wellgistics Health.

Financial Health

General

Q3 2025YOY Change
Revenue$3.01M-46.9%
Gross Profit-$571.78K-1162.4%
Gross Margin-18.98%-19.9%
Market Cap$74.75M0.0%
Net Income-$34,318.20K-1738.1%
EBITDA-$30,745.54K-2283.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$4.23M433.1%
Accounts Receivable$1.10M-60.6%
Inventory7.5-23.7%

Liabilities

Q3 2025YOY Change
Long Term Debt$13.26M5.6%
Short Term Debt$12.94M35.8%

Ratios

Q3 2025YOY Change
Return On Assets-143.52%0.0%
Return On Invested Capital54.76%0.0%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$1,135.33K-185.6%
Operating Free Cash Flow-$1,135.33K-185.6%

Valuation

MetricQ1 2025Q2 2025Q3 2025YoY Change
Price to Book33.3213.2961.86-
Price to Sales9.161.662.33-
Price to Tangible Book Value-7.05-1.77-1.53-
Enterprise Value to EBITDA-9.45-18.22-3.30-
Return on Equity-357.7%-5209.1%-927.7%-
Total Debt$25.11M$25.74M$24.87M$26.20M18.65%

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.